Nitric oxide, the biological mediator of the decade: Fact or fiction?

European Respiratory Journal

Volumn 10, Issue 3, 1997, Pages 699-707

  Singh, S ^a   Evans, T W ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

acute respiratory distress syndrome; hypoxic pulmonary vasoconstriction; nitric oxide; nitric oxide synthase; pulmonary hypertension; reactive oxygen species

Indexed keywords

BIOLOGICAL MARKER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE;

ADULT RESPIRATORY DISTRESS SYNDROME; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; HUMAN; INTENSIVE CARE; PHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; VASOCONSTRICTION;

ANIMALS; CARDIOVASCULAR DISEASES; FREE RADICALS; GASTROINTESTINAL DISEASES; HOMEOSTASIS; HUMANS; LUNG; LUNG DISEASES; NEUROTRANSMITTER AGENTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 0031048389     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (112)

1. Furchgott RF, Zawadski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376 .
2. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84: 9265-9269.
3. Palmer RM, Ferrtige AG, Moncada S. Nitric oxide release accounts for the biological activity of endotheliumderived relaxing factor. Nature 1987; 327: 524-526.
4. Zapol WM, Rimar S, Gillis N, Marletta M, Bosken CH. Nitric oxide and the lung. Am J Respir Crit Care Med 1994; 149: 1375-1380.
5. Liu SF, Adcock IM, Old RW, Barnes PJ, Evans TW. Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA. Biochem Biophys Res Commun 1993; 196: 1208-1213.
6. Griffiths MJD, Liu S, Curzen NP, Messant M, Evans TW. In vivo treatment with lipopolysaccharide induces nitric oxide synthase in rat main pulmonary arteries. Am J Physiol 1995; 268: L509-L518.
7. Marsden PA, Heng HHQ, Scherer SW, et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 1993; 268: 17478-17488.
8. Janssens SP, Shimouchi A, Quertermous T, Bloch DB, Bloch KD. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor, nitric oxide synthase. J Biol Chem 1992; 267: 14519-14522.
9. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 1991; 351: 714-718.
10. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-141.
11. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6: 3051-3064.
12. Hamid Q, Springall DR, Riveros-Moreno V, et al. Induction of nitric oxide synthase in asthma. Lancet 1993; 342: 1510-1513.
13. Tracey WR, Xue C, Klinghoffer V, et al. Immunocytochemical detection of nitric oxide synthase in asthma. Am J Physiol 1994; 266: L722-727.
14. Adcock IM, Brown CR, Kwon OJ, Barnes PJ. Oxidative stress induces NF-KB DNA-binding and inducible NOS mRNA in human epithelial cells. Biochem Biophys Res Commun 1994; 199: 1518-1524.
15. Barnes PJ. NO or no NO in asthma? Thorax 1996; 51 : 218-220.
16. Beckman JS, Crow JP. Pathological implications of nitric oxide, Superoxide and peroxynitrite formation. Biochem Soc Trans 1993; 21: 330-334.
17. Van der vliet A, Smith D, O'Neill CA, et al. Interactions of peroxynitrite with human plasma and its constituents: oxidant damage and antioxidant depletion. Biochem J 1994; 303: 295-301.
18. Myers PR, Minor RL, Guerra R, Bates JN, Harrison DB. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble 5-nitrocysteine than nitric oxide. Nature 1990; 345: 161-163.
19. Petros A, Bennett D, Vallance P. Effect of nitric oxide inhibitors on hypotension in patients with septic shock. Lancet 1991; 338: 1557-1558.
20. Griffiths MJD, Curzen NP, Sair M, Evans TW. Nitric oxide synthase inhibitors in septic shock: theoretical considerations. Clin Intens Care 1994; 5: 29-36.
21. Griffith TM, Edwards DH, Davies RL, Harrison TJ, Evans KT. EDRF co-ordinates the behaviour of vascular resistance vessels. Nature 1987; 329: 442-445.
22. Vallance P, Collier J. Biology and clinical relevance of nitric oxide. BMJ 1994; 309: 453-457.
23. Liu SF, Crawley DE, Barnes PJ, Evans TW. Endotheliumderived nitric oxide inhibits pulmonary vasoconstriction in isolated blood perfused rat lungs. Am J Respir Rev 1991; 143: 32-37.
24. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995; 333: 214-221.
25. Dinh-Xuan AT. Endothelial modulation of pulmonary vascular tone. Eur Respir J 1992; 5: 757-762.
26. Crawley DF, Liu SF, Evans TW, Barnes PJ. Inhibitory role of endothelium-derived nitric oxide in rat and human pulmonary arteries. Br J Pharmacol 1990; 101: 166-170.
27. Altiere RJ, Thompson DC. Modulation of cholinergic response by N-nitro-L-arginine in rabbit intrapulmonary arteries. Pulmon Pharmacol 1992; 5: 149-151.
28. Calver A, Collier J, Vallance P. Nitric oxide and cardiovascular control. Exp Physiol 1993; 78: 303-326.
29. Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987; ii: 1057-1058.
30. Azuma H, Ishikawa M, Sekizaki S. Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol 1986; 88: 411-415.
31. Mendelsohn ME, O'Neill S, George D, Loscalzo J. Inhibition of fibrinogen-binding to human platelets by S-nitroso-N-acetylcysteine. J Biol Chem 1990; 265: 19028-19034.
32. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler RG, Simmons RL. Negative inotropic effect of cytokines on the heart mediated by nitric oxide. Science 1992; 257: 387-389.
33. Henderson AH, Lewis MJ, Shah AM, Smith JA. Endothelium, endocardium and cardiac contraction. Cardiovasc Res 1992; 26: 305-308.
34. Belvisi MG, Stratton CD, Barnes PJ. Nitric oxide is the neurotransmitter of bronchodilator nerves in human airways. Eur J Pharmacol 1992; 210: 221-222.
35. Lammers JWJ, Barnes PJ, Chung KF. Nonadrenergic, noncholinergic airway inhibitory nerves. Eur Respir J 1992; 5: 239-246.
36. Bames PJ. Nitric oxide and airways. Eur Respir J 1993; 6: 163-165.
37. Buga GM, Ignarro LJ. Electrical field stimulation causes endothelium-dependent and nitric oxide-mediated relaxation of the pulmonary artery. Am J Physiol 1992; 262: L973-L979.
38. Bredt D, Huang P, Dawson T, Fishman M, Snyder S. Nitric oxide synthase knockout mice: molecular and morphological characterization. Endothelium 1993; 1 (Suppl.): S6.
39. Burnett AL, Lowenstein CJ, Bredt DS, Chang TSK, Snyder SH. Nitric oxide: a physiological mediator of penile erection. Science 1992; 257: 401-403.
40. O'Dell TJ, Hawkins RD, Kundel ER, Arancio O. Tests of the role of two diffusable substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc Natl Acad Sci USA 1991; 88: 11285-11289.
41. Bagetta G, Iannone M, Del Duca C, Nistico G. Inhibition by N-nitro-L.-arginine methylester of the electrocortical arousal response in rats. Br J Pharmacol 1993; 108: 858-860.
42. Moore PK, Babbedge RC, Wallace P, Geffen ZA, Hart SL. 7-Nitro indazole, an inhibitor of nitric oxide synthase exhibits antinociceptive activity in in the mouse without increasing blood pressure. Br J Pharmacol 1993; 108: 296-297.
43. Haley JE, Dickenson AH, Schacter M. Electrophysiological evidence for the role of nitric oxide in prolonged chemical nociception in the rat. Neuropharmacology 1992; 31: 257-258.
44. Hibbs JB Jr. Synthesis of nitric oxide from L-arginine: a recently discovered pathway induced by cytokines with antitumour and antimicrobial activities. Res Immunol 1991; 142: 565-569.
45. O'Donnell C, Liew E. Immunological aspects of nitric oxide. The Biochemist 1994; 16(5): 19-22.
46. Liew FY, Li Y, Severn A, et al. A possible novel pathway of regulation by murine T-helper type 2 cells (Th2) of Th1 cell activity via the modulation of the induction of nitric oxide synthase in macrophages. Eur J Immunol 1991; 21: 2489-2494.
47. Jain B, Lubinstein I, Robbins RA, Leise KL, Sisson JH. Modulation of airway epithelial cell ciliary beat frequency by nitric oxide. Biochem Biophys Res Commun 1993; 191: 83-88.
48. Vallance P, Moncada S. Role of endogenous nitric oxide in septic shock. New Horizons 1993; 1: 77-87.
49. Benjamin N, O'Driscoll F, Dougall H, et al. Stomach NO synthesis. Nature 1994; 368: 502.
50. Vidal MJ, Romero JC, Vanhoutte PM. Endotheliumderived relaxing factor inhibits renin release. Eur J Pharmacol 1988; 149: 401-402.
51. Tolins JP, Schultz PJ. Endogenous nitric oxide synthesis determines sensitivity to the pressor effect of salt. Kidney Int 1994; 46: 230-236.
52. Conrad JP, Joffe GM, Kruszyna R, et al. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J 1993; 7: 566-571.
53. Moncada S, Higgs A. Mechanisms of disease: the L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-2012.
54. Calver A, Collier J, Vallance P. Nitric oxide and cardiovascular control. Exp Physiol 1993; 78: 303-326.
55. Marsden PA, Heng HHQ, Scherer SW, et al. Structure and chromosomal localization of the human constitutive nitric oxide synthase gene. J Biol Chem 1993; 268: 17478-17488.
56. Snyder SH. Janus faces of nitric oxide. Nature 1993; 364: 577.
57. Liu SF, Adcock IM, Old RW, Barnes PJ, Evans TW. Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA. Biochem Biophys Res Commun 1993; 196: 1208-1213.
58. Hibbs JB Jr, Westenfelder C, Taintor R, et al. Evidence for cyokine-inducible nitric oxide synthesis is from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest 1992; 89: 867-877.
59. Evans TE, Carpenter A, Kinderman H, Cohen J. Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 1993; 41: 77-81.
60. Schneider F, Lutun P, Vouchot A, Bilbault P, Tempe JD. Plasma cyclic guanosine 3'-5' monophosphate concentrations and low vascular resistance in human septic shock. Intensive Care Med 1993; 19: 99-104.
61. Rees DD, Cellek S, Palmer RMJ, Moncada S. Dexamethasone prevents the induction by endotoxin of nitric oxide synthase and associated effects on vascular tone: an insight into endotoxic shock. Biochem Biophys Res Commun 1990; 173: 541-547.
62. Griffiths MJD, Liu S, Curzen NP, Messant M, Evans TW. In vivo treatment with endotoxin induces nitric oxide synthase in rat main pulmonary arteries. Am J Physiol 1995; 268: L509-L518.
63. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Am J Respir Crit Care Med 1994; 149: 818-824.
64. Dantzer DR, Brook CJ, Dehart P, Lynch JP, Weg JG. Ventilation-perfusion distributions in the adult respiratory distress syndrome. Am Rev Respir Dis 1979; 120: 1039-1052.
65. Calvin JE, Quin B. Right ventricular pressure overload during acute lung injury: cardiac mechanics and the pathophysiology of right systolic dysfunction. J Crit Care 1989; 4: 251-265.
66. Pinsky MR. The role of the right ventricle in determining the cardiac output in the critically ill. Intensive Care Med 1993; 19: 1-2
67. Wagenvoort CA. Grading of pulmonary vascular lesions: a reappraisal. Histopathology 1981; 5: 595-598.
68. Wood P. Pulmonary hypertension with special reference to the vasoconstrictive factor. Br Heart J 1958; 20: 557-570.
69. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 1989; 3: 2007-2018.
70. Roberts JD Jr, Polaner DM, Leng P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340: 818-819.
71. Altiere RJ, Thompson DC. Modulation of cholinergic response by N-nitro-L-arginine in rabbit intrapulmonary arteries. Pulm Pharmacol 1992; 5: 149-151.
72. Loscalzo J. Endothelial dysfunction in pulmonary hypertension. N Engl J Med 1992; 327: 117-119.
73. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne E, Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343: 133-135.
74. Hamid Q, Springall DR, Riveros-Moreno V, et al. Induction of nitric oxide synthase in asthma. Lancet 1993; 342: 1510-1513.
75. Kharitonov SA, O'Connor BJ, Evans DJ, Barnes PJ. Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am J Respir Crit Care Med 1995; 151: 1894-1899.
76. Massaro AF, Gaston B, Kita D, Fanta C, Stamler J, Drazen JM. Expired nitric oxide levels during treatment for acute asthma. Am J Respir Crit Care Med 1995; 152: 800-803.
77. Barnes PJ, Kharitonov SA. Exhaled nitric oxide: a new lung function test. Thorax 1996; 51: 233-237.
78. Kharitonov SA, Wells AU, O'Connor BJ, Hansell DM, Cole PJ, Barnes PJ. Elevated levels of nitric oxide in bronchiectasis. Am J Respir Crit Care Med 1995; 151: 1889-1893.
79. Riegel F. Diseases of the trachea and bronchi. In: Ziemssen HV, ed. Cyclopaedia of the Practice of Medicine. Vol. 4. London, Sampson, Low, Martson, Saerle and Rivington, 1876; pp. 275-586.
80. Vallance P, Collier J. Biology and clinical relevance of nitric oxide. BMJ 1994; 309: 453-457.
81. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in the coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 1991; 338: 1546-1550.
82. Eddahibi S, Adnot S, Carville C, Blouquit Y, Raffestin B. L-arginine restores endothelium-dependent relaxation in pulmonary circulation of chronically hypoxic rats. Am J Physiol 1992; 263: L194-L200.
83. Vosatka RJ, Kashyap S, Trifiletti RR. Arginine deficiency accompanies persistent pulmonary hypertension of the newborn. Biol Neonate 1994; 66: 65-70.
84. Quinn AC, Petros AJ, Vallance P. Nitric oxide: an endogenous gas. Br J Anaesth 1995; 74: 443-451.
85. Grover R, Murdoch I, Smithies M, Mitchell I, Bihari D. Nitric oxide during hand ventilation in a patient with acute respiratory failure. Lancet 1992; 340: 818-819.
86. Kinsella JP, Neish SR, Shaffer E, Arman SH. Lowdose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340: 819-820.
87. Adatia I, Thomson J, Landzberg M, Wessel D. Inhaled nitric oxide in chronic obstructive lung disease. Lancet 1993; 341: 307-308.
88. Adnot S, Kouyoumdjian C, Defouilloy C, et al. Haemodynamic and gas exchange responses to infusions of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension. Am Rev Respir Dis 1993; 148: 310-316.
89. Brett SJ, Evans TW. Nitric oxide: physiological roles and therapeutic implications in the lung. Br J Hosp Med 1995; S5(2): 1-4.
90. Frostell CG, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991; 83: 2038-2047.
91. Frattaci MD, Frostell CG, Chen TY, Wain JC, Robinson DR, Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. Anaesthesiology 1991; 75: 990-999.
92. Frostell CG, Blomquist H, Hedenstierna G, Lindberg J, Zapol WM. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anaesthesiology 1993; 78: 427-435.
93. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328: 399-405.
94. Puybasset L, Rouby JJ, Mourgeon E, et al. Inhaled nitric oxide in acute respiratory failure: dose response curves. Intensive Care Med 1994; 20: 319-327.
95. Bigaletto LM, Hurford WE, Kacmarek RM, Roberts JD, Zapol WM. Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome: effects on pulmonary haemodynamics and oxygenation. Anaesthesiology 1994; 80: 761-770.
96. Krafft P, Fridrich P, Fitzgerald RD, Koc D, Steltzer H. Effectiveness of nitric oxide inhalation in septic ARDS. Chest 1996; 109: 486-493.
97. Mira JP, Monchi M, Brunet F, Fierobe L, Dhainaut JF, Dinh-Xuan AT. Lack of efficacy of inhaled nitric oxide in ARDS. Intensive Care Med 1994; 20: 532.
98. Ricou B, Suter PM. Variable effects of nitric oxide (NO) in ARDS patients (Abstract). Am Rev Respir Dis 1993; 147: A350.
99. Brett SJ, Evans TW. Inhaled vasodilator therapy in acute lung injury: first, do NO harm? Thorax 1995; 50: 821-823.
100. Barbera JA, Roger N, Roca J, Rovira I, Higenbottam TW, Rodriguez-Roisin R. Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease. Lancet 1996; 347: 436-440.
101. Scherrer U, Vollenweider L, Delabays A, et al. Inhaled nitric oxide for high altitude pulmonary oedema. N Engl J Med 1996; 334: 624-629.
102. Walmrath D, Schneider T, Schermuly R, et al. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. Am J Respir Crit Care Med 1996; 153: 991-996.
103. MiskoTP, Moore WM, Kasten TP, et al. Selective inhibition of inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 1993; 233: 119-125.
104. Hasan K, Heeson BJ, Corbett JA, et al. Inhibition of nitric oxide formation by guanidines. Eur J Pharmacol 1993; 249: 101-106.
105. Lundberg JON, Weitzberg E, Lundberg JG, Alving K. Nitric oxide in exhaled air. Eur Respir J 1996; 9: 2671-2680.
106. Rubanyi GM, Ho EH, Cantor EH, Lumma WC, Parker Botelho LH. Cytoprotective function of nitric oxide: inactivation of Superoxide radicals produced by human leukocytes. Biochem Biophys Res Commun 1991; 181: 1392-1397.
107. Fukahori M, Ichimori K, Ishida H, Nakagawa H, Okino H. Nitric oxide reversibly suppresses xanthine oxidase activity. Free Rad Res 1994; 21: 203-212.
108. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical protection by peroxynitrite: implications for endothelial injury from nitric oxide and Superoxide. Proc Natl Acad Sci USA 1990; 57: 1620-1624.
109. Kooy NW, Royall JA, Kelly DR, Beckman JS. Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respir Crit Care Med 1995; 151: 1250-1254.
110. Stavert DM, Lehnert BE. Nitrogen oxide and nitrogen dioxide as inducers of acute pulmonary injury when inhaled at relatively high concentrations for brief periods. Inhal Toxicol 1990; 2: 53-57.
111. Hugod C. Effects of exposure to 43 ppm nitric oxide and 3-6 ppm nitrogen dioxide on rabbit lung. Int Arch Occup Environ Health 1979; 42: 159-167.
112. Oda H, Nogami H, Kusomoto S, Nakajima T, Kurata A, Imai K. Long-term exposure to nitric oxide in mice. J Jpn Soc Air Pollut 1976; 11: 150-160.